Ami Fadia
Stock Analyst at Needham
(1.2)
# 1953
Out of 5,358 analysts
493
Total ratings
44.19%
Success rate
1.82%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
IMRX Immuneering | Reiterates: Buy | 9 9 | 2.15 | 318.6% | 16 | Jun 5, 2025 | |
JAZZ Jazz Pharmaceuticals | Reiterates: Buy | 202 202 | 111.11 | 81.8% | 31 | Jun 3, 2025 | |
BPMC Blueprint Medicines | Downgrades: Hold | 130 130 | 127.82 | 1.71% | 31 | Jun 2, 2025 | |
CNTA Centessa Pharmaceuti... | Initiates Coverage On: Buy | 35 | 11.91 | 193.87% | 1 | May 28, 2025 | |
ALKS Alkermes | Initiates Coverage On: Buy | 45 | 31.72 | 41.87% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 75 88 | 56.23 | 56.5% | 29 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 27 30 | 21.97 | 36.55% | 9 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 1.05 | 376.19% | 9 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 57 57 | 41.1 | 38.69% | 23 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 19 19 | 9.74 | 95.07% | 36 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 27 | 7.17 | 276.57% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 49 49 | 35.58 | 37.72% | 37 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 138 139 | 125.42 | 10.83% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 44.52 | 79.69% | 11 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 29 29 | 8.6 | 237.21% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 40 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 153 153 | 111.92 | 36.7% | 14 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 22 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 27 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 6 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 7 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | n/a | n/a | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | n/a | n/a | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 28 26 | n/a | n/a | 6 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 240 320 | 12.75 | 2409.8% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 63 75 | 25.97 | 188.79% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 5 | n/a | n/a | 2 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 10 14 | n/a | n/a | 3 | Oct 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 15 23 | 0.97 | 2219.59% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 64 63 | 26.16 | 140.83% | 4 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 2 | n/a | n/a | 8 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 10 | n/a | n/a | 2 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 24 | n/a | n/a | 8 | Jan 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 20 | n/a | n/a | 2 | Sep 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 12 5 | 4.18 | 19.62% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Perform | n/a | n/a | n/a | 7 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 12 | n/a | n/a | 5 | Jan 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 22 | 2.1 | 947.62% | 4 | Jan 3, 2018 |